Delivery Order SPE2DB20D9331-SPE2DB24FL0W1

Award Date 3/21/24
Potential Completion Date 3/22/24
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $4,542.72, is a firm-fixed price delivery order for the supply of various pharmaceutical products, including medications such as FOSAMAX 70 MG TABLET. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency. The contract is a delivery order with a firm fixed price valued at $9,464.00, with a completion date of March 8, 2024. The contract is not set aside for any specific business type. DMS Pharmaceutical Group Inc. is providing the pharmaceutical product FOSAMAX 70 MG TABLET under this award. The company holds a larger indefinite delivery contract, contract 4600082013...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,217.76 contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a branded pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is not associated with a specific set-aside designation, allowing DMS Pharmaceutical Group to...
This federal contract award, SPE2DX15D9348|SPE2DX24FBDTZ, was issued by the Medical Supply Chain division of the Defense Logistics Agency to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $11,356.80 firm fixed-price delivery order is for the supply of 4,563,998,871 units of the pharmaceutical product FOSAMAX 70 MG TABLET. This award is part of DMS Pharmaceutical Group's broader Prime Vendor contract 4600082013 with DLA,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a range of pharmaceutical products. The contract, valued up to $2,284.16, is a delivery order under the DLA's SPE2DB program, which is an indefinite delivery vehicle (IDV) with a ceiling of up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical Group will fulfill recurring medical supply needs of military health facilities, including...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,542.72 delivery order is for the supply of Fosamax 70 mg tablets, with a performance period ending on January 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA to provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide....
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a firm fixed-price delivery order contract valued at $9,464.00 by the Defense Logistics Agency. The contract is for the delivery of Fosamax 70 mg tablets and has a completion date of February 8, 2024. This delivery order is issued under a larger indefinite delivery vehicle (IDV) contract #4600082013, the SPE2DB program, with a potential value of up to $4,999,999 through the end of 2025. The SPE2DB IDV enables the DLA to...
This federal contract award is a $5,435.86 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Otezla 30 mg tablets, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This federal contract award, valued at $45,987.19, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order (SPE2DB24D2106|SPE2DB24FAUKV) for the provision of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order, is valued at $37,053.68 and has an ultimate completion date of July 19, 2024. The contract is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL0W1
    Delivery Order

This federal contract award is for the delivery order SPE2DB24FL0W1 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,266.40 firm fixed-price contract, with a completion date of March 22, 2024, is for the supply of 4,564,153,024 FOSAMAX 70 MG tablet units.

The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides both routine and critical medications through this IDC, solidifying its position as a key supplier in the federal pharmaceutical supply chain. This contract award does not have a set-aside designation.

Generated 1/9/25, 9:27 AM